Review
Open access
Jul 2026
Dynamic phenotype monitoring to prevent genotype–phenotype discrepancies in pharmacogenetic-guided drug therapy
An integrated analysis of routine (CRP, transaminases), functional, and molecular biomarkers offers a novel strategy for interpreting clinically significant genotype–phenotype discordance and anticipate potential variations in drug exposure tolerance.
Pálma Porrogi
· Frontiers in Pharmacology · 0 citations